Follow Slashdot blog updates by subscribing to our blog RSS feed

 



Forgot your password?
typodupeerror
×
Medicine

FDA Approves Most Expensive Drug Ever, a $3.5 Million-per-Dose Gene Therapy For Hemophilia B (cbsnews.com) 195

U.S. health regulators this week approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder. From a report: The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common form of the genetic disorder which primarily affects men. Currently, patients receive frequent, expensive IVs of a protein that helps blood clot and prevent bleeding. Drugmaker CSL Behring, based in Pennsylvania, announced the $3.5 million price tag shortly after the FDA approval, saying its drug would ultimately reduce health care costs because patients would have fewer bleeding incidents and need fewer clotting treatments.

According to a study cited by the National Library of Medicine, the price makes Hemgenix the most expensive medicine in the world, easily topping Novartis' Zolgensma gene therapy for spinal muscular atrophy (SMA), which costs right around $2 million per dose and is also a single-dose medicine. Like most medicines in the U.S., most of the cost of the new treatment will be paid by insurers, not patients, including private plans and government programs. After decades of research, gene therapies have begun reshaping the treatment of cancers and rare inheritable diseases with medicines that can modify or correct mutations embedded in people's genetic code. Hemgenix is the first such treatment for hemophilia and several other drugmakers are working on gene therapies for the more common form of the disorder, hemophilia A.

This discussion has been archived. No new comments can be posted.

FDA Approves Most Expensive Drug Ever, a $3.5 Million-per-Dose Gene Therapy For Hemophilia B

Comments Filter:
  • by Joe_Dragon ( 2206452 ) on Thursday November 24, 2022 @06:14PM (#63077772)

    NON USA COST $35 Dose

    • by cirby ( 2599 )

      More like $35,000. ...in a couple of decades, at best.

      And most countries won't use it because it's "too expensive."

      • by quenda ( 644621 )

        More like $35,000. ...in a couple of decades, at best.

        And most countries won't use it because it's "too expensive."

        I'd have thought that. But checking Zolgensma in Australia: https://www.pbs.gov.au/medicin... [pbs.gov.au]

        It is approved on the Pharmaceutical Benefits Scheme! Cost $2,527,773.87. Charge to patient: $42.50

        • by gweihir ( 88907 )

          That will be AUD. 1 AUD = 0.672852 USD, so this is actually 1,700,558.64 USD.

          Wonder what makes this stuff about 2x as expensive in the US? Some executive needs to finance another villa or maybe a yacht?

    • by Jeremi ( 14640 )

      Non USA cost is "not available at any price".

      Of course, the in-USA cost is effectively "not available at any price" also, for anyone who isn't either a billionaire or extraordinarily well-insured. Hopefully the prices for this sort of thing will come down at some point to where they can be used to help more than a token number of people.

      • by rsilvergun ( 571051 ) on Thursday November 24, 2022 @07:35PM (#63077944)
        why not just make it happen? We don't need the pharma companies. They spend a fraction of their money on research and focus only on finishing up work the gov't started. There's no reason why we couldn't do that in public universities (like the rest of the civilized world).

        Go google some of Katie Porter's bits on big pharma if you doubt me.

        We don't need them. And they're parasites. Why keep them around? It's time to get over grade school propaganda we were taught in 10th grade economics.
        • Re: (Score:2, Interesting)

          by Jeremi ( 14640 )

          why not just make it happen? We don't need the pharma companies. They spend a fraction of their money on research and focus only on finishing up work the gov't started. There's no reason why we couldn't do that in public universities (like the rest of the civilized world).

          If the rest of the world has this problem solved, great -- hemophiliacs can just fly to a foreign country and get their dose of this treatment (or something equivalent) there, for a much lower price. Or if that's not possible, then perhaps that is the answer to your question.

        • Cost is rarely a Government priority, Falcon 9 and the Falcon Heavy have the cheapest launch costs of all comparable alternatives developed by Governments around the World.
        • by AmiMoJo ( 196126 )

          When you look at the world pharma R&D budget, a big block like the EU or US or China could easily afford to take it all on and make the resulting treatments available royalty free. Ideally they could all get together and fund that work.

        • We don't need the pharma companies. They spend a fraction of their money on research and focus only on finishing up work the gov't started.

          Not really. Don't confuse what a few American pharma companies do with their role on the wider world stage. There's some very real cost from taking something a university spat out to actual production at any kind of usable scale.

          The rest of the world is highly reliant on pharma companies too, the difference is they don't have this ludicrous pricing scheme from the USA. Fix that, but don't throw the baby out with the bathwater just because your understanding of the industry is very narrow.

        • by thejam ( 655457 )

          If I create some new incredibly useful invention, but keep it secret, by what right can you shake me down for it?

      • by narcc ( 412956 )

        Non USA cost is "not available at any price".

        False [slashdot.org]

        Oh, did that fact just destroy your absurd exceptionalist fantasy? Sorry!

        • That is about a different drug.

          While I suspect this drug will also be available, you have again demonstrated your exceptional ability to not understand logical truths, as the non-USA cost is indeed "Not available at any price" (at this juncture)
      • by gweihir ( 88907 )

        Not true, see reference by quenda. The US is deeply corrupted by greed, do not try to make that look ok by lying about the rest of the world.

    • The data in this chart is from 2018. We can only imagine the further divergence in 2022.

      https://www.rand.org/blog/rand... [rand.org]

    • $35 for a prescription's very expensive! You'd probably get an older but still just as effective treatment in Cuba for $0.35 (Maybe clotting agents & blood transfusions?). BTW, the flat-rate prescription charge where I live is 1.27€. No matter what your prescription is, that's what they charge. If you're young, retired, unemployed, poor or whatever, they waive the charge. We're just a bunch of bloody socialists, mate.
      • It doesn't always work out. There's a medication I take that I have to take the XR version or I get incredibly sick. It's not available outside of the US. I ran into problems while traveling overseas because I couldn't get it.
        • It's not available outside of the US.

          I wonder why? I also wonder how the rest of the world treats this condition. In countries with universal healthcare, a visit to the doctor & a prescription without healthcare coverage won't bankrupt you. It ain't the USA!

  • Fun fact (Score:5, Insightful)

    by rsilvergun ( 571051 ) on Thursday November 24, 2022 @06:16PM (#63077778)
    The technology that made this possible was developed at public universities using taxpayer dollars. Privatize the profits, socialize the expenses. Are we ever going to get tired of them doing this to us?
    • Re:Fun fact (Score:4, Insightful)

      by The Evil Atheist ( 2484676 ) on Thursday November 24, 2022 @06:31PM (#63077818)
      Don't worry. In a few hours, you'd be inundated with nerds saying why this is actually a good thing.
      • Re:Fun fact (Score:5, Interesting)

        by rsilvergun ( 571051 ) on Thursday November 24, 2022 @07:30PM (#63077934)
        Honestly they mostly just deny it. They look at the tail end research the pharma company did (the cheap stuff) and ignore the 20-30 years of unprofitable and *very* expensive basic research that lead up to them being able to monetize it. Then they call for more tax cuts to education and complain about student loan forgiveness while ignoring the massive state & federal subsidies that made their college educations cheap.
        • They seem incapable of understanding flow-on effects, feedback loops, and consequences beyond a single point in time.

          "Hey, it seems to produce one beneficial effect in isolation! That's all I need to consider! My queen took a pawn, therefore, I'm slightly ahead, therefore I win the whole game!"
        • Re:Fun fact (Score:4, Insightful)

          by excelsior_gr ( 969383 ) on Friday November 25, 2022 @01:28AM (#63078344)
          I studied at a university 100% paid for by the state. I did my PhD at a university in another country for a basic research program, also paid 100% by the state. If there is anyone grateful for government sponsoring, that would be me. The problem is that basic research is SO basic that no company would even consider paying for it. The chances that it adds up to nothing are huge! But if the government doesn't run the basic research programs, the innovation in the country will just wither and die. It would be great if private companies would pick up even a small fraction of the tab, but the risk is so large, they might as well consider it charity. That's just the reality of it.
    • The technology that made this possible was developed at public universities using taxpayer dollars. Privatize the profits, socialize the expenses. Are we ever going to get tired of them doing this to us?

      And what stopped the university commercialising it? It's about the same difference as theory vs a product on the shelf. There's more involved in producing drugs than just doing some R&D at a university.

      That said there's no justification for this price tag at all, but man the "evil big pharma" crap is getting tiring. Yeah, there's some real fucks in the world, but let's not pretend that means we can just go at it without pharma companies.

  • by SchroedingersCat ( 583063 ) on Thursday November 24, 2022 @06:21PM (#63077790)

    the cost of the new treatment will be paid by insurers, not patients

    There is one little snag - the insurers are funded by "patients". 3.5M treatment is well beyond what a single person contributes back to the society. At what point the treatment becomes too expensive to justify?

    • Really this. Anyone who pays their own insurance knows all too well.
    • by ceoyoyo ( 59147 ) on Thursday November 24, 2022 @06:41PM (#63077844)

      The treatment is justified as being cheaper than the alternative. So your real question is "why don't we dash hemophiliac babies on the rocks before they become a burden?"

    • Are you sure your insurance companies are not printing their own money?
    • It's doesn't cost $3.5M to give patients clotting agents & blood transfusions when they need it. Any decent universal healthcare system can & does easily manage incidents for 1 in 40,000 of the population with this condition.
      • Are clotting agents and blood transfusions effective compared to the alternatives? What side effects do they have? What is their effect on lifestyle? How does blood type availability affect their odds of effective treatment?

        I saw somewhere else that the alternative treatment for hemophilia B has an MSRP of something like $30,000 per week. Based on some other clues, this appears to be Xyntha, which is, according to Wikipedia, "a recombinant antihemophilic factor genetically engineered from Chinese hamster ov

    • how many people's lives could you save or improve if you used just half of this amount.

      Tell all those people living in poverty, that you are worth so much more than they are. That your inconvenience needs to be alleviated and that you don't give a damn if they have enough to eat.

      Now if some twit like Bezos wants to buy this, go ahead, but please do not make the rest of the population pay for it.

      • by narcc ( 412956 )

        You're really bad at this. Your buddies on 8chan or whatever might not know how taxes work, but the majority of people here do.

        Take your bullshit elsewhere.

    • by whoever57 ( 658626 ) on Thursday November 24, 2022 @08:02PM (#63077980) Journal

      The insurance company isn't paying this amount.

      I take Elliquis. Nominally, a month's supply costs about $500. But the manufacturer offers a coupon that brings the cost down to $10/month. It's $10/month for me even before I have met my deductible.

      Clearly, the insurance company isn't paying $500/month, just as the insurance company isn't going to pay $3.5M for this treatment.

    • ...a single "POOR" person perhaps but a person making 100k yr for 35yrs of employment isn't unheard of.
  • I was surprised they did this for the very rare B first instead of the more common A, no pharmaceutical company would go through expensive FDA trials to treat a rare disease when they can focus on the more common one first using the same technology. Then I realised that this is the rare strain the European royal family has.

    Feels good when you can redirect the resources of the entire globe to solve your own person problems before everyone else's.
    • How do you know the research done for this drug won’t be of any future use?

    • Re:Very rare disease (Score:4, Informative)

      by quantaman ( 517394 ) on Thursday November 24, 2022 @06:36PM (#63077834)

      I was surprised they did this for the very rare B first instead of the more common A, no pharmaceutical company would go through expensive FDA trials to treat a rare disease when they can focus on the more common one first using the same technology. Then I realised that this is the rare strain the European royal family has.

      Feels good when you can redirect the resources of the entire globe to solve your own person problems before everyone else's.

      It looks like that particular strain died out in the 1940's [wikipedia.org] so I'm not sure it's a big concern in the present day.

      It also accounts for 15% of Hemophilia patients, so unusual, but not "very rare".

      I suspect the reason for Hemophilia B is something less conspiratorial like the particular mutation somehow being easier to treat or of the different groups trying to do this with different diseases at different companies this particular Hemophilia B group was the fastest.

  • This is largely why our health-care costs keep going up: pharma makes an expensive treatment, and insurance feels obligated because the alternative is great suffering or death of the patient. They pull on our heart-strings. Just up-front say *no* approving anything above a threshold and they'll stop trying.

    It's like paying ransom: the more you pay up, the more kidnappers & hackers get into the biz.

    • They pull on our heart-strings.

      I know what you mean. It's like when Republicans say they're passing anti-abortion laws to protect the "child" even if it kills the mother.

      • by dohzer ( 867770 )

        They pass abortion-restricting laws to increase the population and then refuse to introduce gun reform laws, which helps to counter the population increase. It's a happy balance.

    • by stabiesoft ( 733417 ) on Thursday November 24, 2022 @06:41PM (#63077850) Homepage
      Rarely do I think insurance is going to do it for the patient. From the article, "Currently, patients receive frequent, expensive IVs of a protein that helps blood clot and prevent bleeding." My guess is that the 3.5M may be cheaper than the current IV method as hard as that is to believe. And in that case, insurance will be all over it like a pig in slop. If the new treatment is more expensive, insurance will probably keep using the old method.

      Looked it up, yep 3.5M is cheaper. Expected lifetime cost of the IV method is 21M. https://www.tandfonline.com/do... [tandfonline.com]

  • by mveloso ( 325617 ) on Thursday November 24, 2022 @06:49PM (#63077862)

    If the normal treatment costs $5k/month for 60 years then this drug is marginally cheaper.

  • Since you're doing gene editing anyway the cost would be the same and you also save decedents from getting hit with a $3 million bill as well.
  • Once a drug company hits $1B of income (not profit) from a drug the patent is voided.

    Generics for everyone!

    • There'd be quite a few years for this drug. Sufferers from the genetic defect are fairly rare, so the patent would probably expire first, even at this large of a charge. Which is part of the reason for the large charge - the company did have to spend the money getting the treatment approved.

      • There's over 30K people with this condition in the US alone, so only 1% of them would need this before they hit a $1B in revenue.
    • by PPH ( 736903 )

      Even simpler than that. Just have the US government declare a "war on hemophilia B" and invoke its rights to bypass the patent holder's claims [wikipedia.org].

  • ``Like most medicines in the U.S., most of the cost of the new treatment will be paid by insurers, not patients, including private plans and government programs.

    And just where do insurers get the money to pay for these exorbitantly priced drugs? Us... the people paying the monthly premiums. Can a $1B/dose drug will be next? Wouldn't surprise me.

  • I personally have no problem with gay people, but isn't everyone entitled to his own opinion? I mean, if that kind of lifestyle bothers you, aren't you allowed to just feel that way? Must you be forced to go through such expensive treatments to cure this so-called "disease"?

    Wait, what?

Genius is ten percent inspiration and fifty percent capital gains.

Working...